Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Lipid metabolism disorders
ADR ID BADD_A01285
ADR Hierarchy
14      Metabolism and nutrition disorders
14.08      Lipid metabolism disorders
Description Pathological conditions resulting from abnormal anabolism or catabolism of lipids in the body. [MeSH]
MedDRA Code 10013317
MeSH ID D052439
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Lipid Metabolism Disorders | Lipid Metabolism Disorder | Metabolism Disorder, Lipid | Metabolism Disorders, Lipid
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01507Mycophenolate mofetil--
BADD_D01508Mycophenolic acid0.002378%
BADD_D01512Nadolol--
BADD_D01527Naltrexone--
BADD_D01530Nandrolone decanoate--
BADD_D01533Naproxen--
BADD_D01535Naratriptan--
BADD_D01536Naratriptan hydrochloride--
BADD_D01541Nebivolol--
BADD_D01542Nebivolol hydrochloride--
BADD_D01546Nefazodone--
BADD_D01547Nefazodone hydrochloride--
BADD_D01550Nelfinavir mesylate--
BADD_D01557Nevirapine0.002652%
BADD_D01563Nicotinate--
BADD_D01567Nilotinib0.007611%
BADD_D01572Nitisinone--
BADD_D01592Obeticholic acid--
BADD_D01595Octreotide acetate--
BADD_D01599Olanzapine0.004736%
BADD_D01600Olanzapine pamoate--
BADD_D01602Olmesartan--
BADD_D01603Olmesartan medoxomil--
BADD_D01611Omega-3-acid ethyl esters--
BADD_D01614Omeprazole--
BADD_D01617Ondansetron0.000032%
BADD_D01624Orlistat--
BADD_D01633Oxaliplatin--
BADD_D01653Paclitaxel0.000560%
BADD_D01654Palbociclib0.000839%
The 9th Page    First    Pre   9 10 11 12 13    Next   Last    Total 15 Pages
ADReCS-Target
ADR Term Drug Name Target